Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors (Q41682186)

7 October 2017

1 reference

title

Drug interactions of clinical significance with selective serotonin reuptake inhibitors (English)

1 reference

7 October 2017

Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors (English)

1 reference

10.2165/00002018-199717060-00005

Crossref

DOI

https://api.crossref.org/works/10.2165/00002018-199717060-00005

cytochrome P-450 enzyme inhibitors

2 December 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9429838

2 December 2024

P. B. Mitchell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9429838

2 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9429838

2 December 2024

publication date

1 December 1997

1 reference

7 October 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9429838

2 December 2024

1 reference

7 October 2017

1 reference

7 October 2017

1 reference

7 October 2017

page(s)

390-406

1 reference

The safety of concomitant use of sumatriptan and antidepressant treatments

7 October 2017

cites work

1 reference

12 December 2020

Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.

1 reference

12 December 2020

Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

1 reference

12 December 2020

Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine

1 reference

12 December 2020

Serotonin syndrome caused by a moclobemide-clomipramine interaction

1 reference

12 December 2020

Toxic serotonin syndrome after fluoxetine plus carbamazepine

1 reference

12 December 2020

Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

CYP3A gene expression in human gut epithelium

1 reference

12 December 2020

Fluoxetine and warfarin interactions

1 reference

12 December 2020

Serotonin syndrome with moclobemide-fluoxetine combination

1 reference

12 December 2020

Delirium Probably Induced by Clarithromycin in a Patient Receiving Fluoxetine

1 reference

12 December 2020

Fluvoxamine-tricyclic antidepressant interaction

1 reference

12 December 2020

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

1 reference

12 December 2020

Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome

1 reference

12 December 2020

Are pharmacokinetic drug interactions with the SSRIs an issue?

1 reference

12 December 2020

Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers

1 reference

12 December 2020

Safety and tolerability of combined treatment with moclobemide and SSRIs: a preliminary study of 19 patients

1 reference

12 December 2020

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

1 reference

12 December 2020

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

1 reference

12 December 2020

Fluoxetine inhibition of phenytoin metabolism

1 reference

12 December 2020

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

12 December 2020

Probable terfenadine-fluoxetine-associated cardiac toxicity

1 reference

12 December 2020

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

1 reference

12 December 2020

Fluoxetine-associated potentiation of calcium-channel blockers

1 reference

12 December 2020

Combined SSRI-moclobemide treatment of psychiatric illness.

1 reference

12 December 2020

Kinetics of citalopram in elderly patients

1 reference

12 December 2020

Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

1 reference

12 December 2020

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

1 reference

12 December 2020

Increased carbamazepine plasma concentrations after fluoxetine coadministration

1 reference

12 December 2020

Effect of sertraline on protein binding of warfarin

1 reference

12 December 2020

Elevated levels of clozapine in serum after addition of fluvoxamine

1 reference

12 December 2020

Fluvoxamine. A review of global drug-drug interaction data

1 reference

12 December 2020

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

12 December 2020

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

12 December 2020

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype

1 reference

12 December 2020

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.

1 reference

12 December 2020

A potential drug interaction between fluoxetine and valproic acid

1 reference

12 December 2020

Fluoxetine and selegiline--lack of significant interaction

1 reference

12 December 2020

Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports

1 reference

12 December 2020

Interactions between sertraline and tricyclic antidepressants

1 reference

12 December 2020

A toxic reaction from combining fluoxetine and phentermine

1 reference

12 December 2020

Serotonin syndrome induced by fluvoxamine-lithium interaction

1 reference

12 December 2020

Function of cytochrome P-450 of microsomes

1 reference

12 December 2020

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

12 December 2020

Citalopram: interaction studies with levomepromazine, imipramine, and lithium

1 reference

12 December 2020

Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients

1 reference

12 December 2020

Newer antidepressants and the cytochrome P450 system

1 reference

12 December 2020

Fatal moclobemide overdose or death caused by serotonin syndrome?

1 reference

12 December 2020

The clinician and drug interactions--an update

1 reference

12 December 2020

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

12 December 2020

Possible interaction of sertraline with carbamazepine

1 reference

12 December 2020

Danger of MAOI therapy after fluoxetine withdrawal

1 reference

12 December 2020

Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.

1 reference

12 December 2020

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

12 December 2020

Molecular genetics of the debrisoquin-sparteine polymorphism

1 reference

12 December 2020

Interaction of fluoxetine with tricyclic antidepressants

1 reference

12 December 2020

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

1 reference

12 December 2020

The P450 gene superfamily: recommended nomenclature

1 reference

12 December 2020

Possible interaction between sertraline and tranylcypromine

1 reference

12 December 2020

Elevation of plasma concentrations of haloperidol after the addition of fluoxetine

1 reference

12 December 2020

Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine, and mephenytoin

1 reference

12 December 2020

Fluoxetine disposition and elimination in cirrhosis

1 reference

12 December 2020

Possible serotonin syndrome associated with tramadol and sertraline coadministration

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

1 reference

12 December 2020

Cytochrome P450 isozymes and antiepileptic drug interactions

1 reference

12 December 2020

The effect of fluoxetine on warfarin metabolism in the rat and man

1 reference

12 December 2020

Possible toxicity of combined fluoxetine and lithium

1 reference

12 December 2020

Interaction of metoprolol and fluoxetine

1 reference

12 December 2020

Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports

1 reference

12 December 2020

Pharmacokinetics of the newer antidepressants: clinical relevance

1 reference

12 December 2020

Inhibitors of imipramine metabolism by human liver microsomes

1 reference

12 December 2020

Plasma level measurement in a patient with clozapine intoxication.

1 reference

12 December 2020

Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site

1 reference

12 December 2020

Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine

1 reference

12 December 2020

Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients

1 reference

12 December 2020

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

1 reference

12 December 2020

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

1 reference

12 December 2020

Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo

1 reference

12 December 2020

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

1 reference

12 December 2020

Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients

1 reference

12 December 2020

Recent Advances: the Cytochrome P450 Enzymes

1 reference

12 December 2020

Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans

1 reference

12 December 2020

Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo

1 reference

12 December 2020

The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease

1 reference

12 December 2020

Serious adverse effects of combining fluoxetine and tricyclic antidepressants

1 reference

12 December 2020

Lack of an Interaction Between Sumatriptan and Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Probable metabolic interaction between methadone and fluvoxamine in addict patients

1 reference

12 December 2020

Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

Human cytochromes P450: problems and prospects

1 reference

12 December 2020

Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice

1 reference

12 December 2020

A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine

1 reference

12 December 2020

Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal.

1 reference

12 December 2020

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

1 reference

12 December 2020

Interaction of fluoxetine with carbamazepine

1 reference

12 December 2020

The serotonin syndrome

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

12 December 2020

Fluoxetine Addition to Methadone in Addicts: Pharmacokinetic Aspects

1 reference

12 December 2020

Paroxetine shifts imipramine metabolism

1 reference

12 December 2020

Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation

1 reference

12 December 2020

Coadministration of fluvoxamine increases serum concentrations of haloperidol

1 reference

12 December 2020

Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate

1 reference

12 December 2020

Increased trimipramine plasma levels during fluvoxamine comedication

1 reference

12 December 2020

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Fluoxetine-warfarin interaction

1 reference

12 December 2020

Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.

1 reference

12 December 2020

Interaction of fluoxetine and selegiline

1 reference

12 December 2020

Interaction between carbamazepine and fluvoxamine

1 reference

12 December 2020

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

1 reference

12 December 2020

A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking

1 reference

12 December 2020

Elevated clozapine plasma concentrations after fluvoxamine initiation

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

12 December 2020

Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients

1 reference

12 December 2020

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

1 reference

12 December 2020

An update of recent moclobemide interaction data

1 reference

12 December 2020

Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants

1 reference

12 December 2020

Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors

1 reference

12 December 2020

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

12 December 2020

A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Drug-drug interactions of fluoxetine with tricyclics

1 reference

12 December 2020

Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin

1 reference

12 December 2020

Effect of sertraline on the pharmacokinetics and protein binding of diazepam in healthy volunteers

1 reference

12 December 2020

Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin

1 reference

12 December 2020

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

1 reference

12 December 2020

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

12 December 2020

Serotonin syndrome produced by a combination of fluoxetine and lithium

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

Adverse consequences of fluoxetine-MAOI combination therapy

1 reference

12 December 2020

A fluvoxamine-caffeine interaction study

1 reference

12 December 2020

Potential terfenadine-fluoxetine interaction

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam

1 reference

12 December 2020

Fluoxetine impairs clearance of alprazolam but not of clonazepam

1 reference

12 December 2020

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.

1 reference

12 December 2020

10.2165/00002018-199717060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

7 October 2017

1043719257

0 references

1 reference